MRNA earnings call for the period ending March 31, 2019.
News & Analysis: Moderna INC
Find out how shares of these biopharmaceutical companies outperformed for some lucky investors with great timing.
The biggest-ever biotech IPO heralds enormous promise for a new class of medicines.
The company's drug cures cancer in mice.
They're largely flying under the radar of most investors.
Here’s what you should know about the public offering of this biotech unicorn this year.
The largest biotech unicorn of its time is trying to get back up after stumbling out of the gate.
Apple got hit with a court order to stop selling older iPhones in China, and the biggest biotech IPO in history is still selling below its offering price.